Comparative Effectiveness of Carvedilol vs Metoprolol Succinate in Heart Failure Patients with an Implantable Cardioverter Defibrillator. Grant uri icon

abstract

  • The research team is conducting a large-scale study with 1,700 participants who have heart failure and are currently being treated with metoprolol succinate. These patients will either continue with their current medication or switch to carvedilol, with each patient being assigned to a group by a random selection process. Researchers will observe the participants for an average of three years. During this time, they will review patients? medical records, asking them to fill out surveys about their life quality, and the research team will carefully track any heart-related issues that arise.

date/time interval

  • January 2025 - December 2027